Hydrocephalus Shunts Market Size (2024 - 2029)

Hydrocephalus Shunts Market Analysis

The Hydrocephalus Shunts Market size is estimated at USD 510.21 million in 2024, and is expected to reach USD 595.83 million by 2029, growing at a CAGR of 3.20% during the forecast period (2024-2029).

Various factors contribute to the market's growth, such as the rising prevalence of brain and neurological disorders, the increasing geriatric population, and the rising adoption of advanced programmable valves in the medical field, particularly in neurosurgery for conditions such as hydrocephalus to improve clinical results and ensure patient safety.

An increase in patients suffering from neurological disorders is expected to be the critical factor contributing to the market's growth. Severe head injuries and meningitis can lead to hydrocephalus by causing bleeding in or around the brain, especially when the infection affects the ventricles or the flow of cerebrospinal fluid (CSF). For instance, according to the Meningitis Weekly Bulletin - West Africa 2023 report, 3,551 CSF were tested for meningitis in week 18 of 2023 in Africa. The high burden of meningitis can lead to an increase in the adoption of hydrocephalus shunts and drive the market's growth. For instance, as per the above-mentioned source, around 10,326 suspected cases of meningitis were reported by 22 countries in week 18 of 2023. Thus, the high number of cases of meningitis-related hydrocephalus is anticipated to boost the adoption of hydrocephalus shunts for its treatment and fuel the market's growth.

Furthermore, strategies of the market players, such as product launches and significant investments in developing innovative hydrocephalus shunts, are expected to propel the market's growth. For instance, in July 2023, Anuncia Medical Inc. launched the next-generation device ReFlow Mini Flusher device for the treatment of patients with hydrocephalus that requires shunting and improves the lives of patients across the United States. Additionally, in February 2023, Rhaeos raised USD 10.5 million in Series A Funding to launch a novel hydrocephalus shunt monitor and accelerate pipeline product development in the United States. These studies help expand the existing shunt portfolio with new devices expected to propel the market over the coming years.

Therefore, owing to factors such as the high burden of neurological disorders, rising research studies for developing advanced shunts, product approvals, and launches by market players, the studied market is anticipated to witness growth. However, shunt malfunction and infection are expected to restrain the market's growth.

Hydrocephalus Shunts Industry Segmentation

As per the scope of the report, a hydrocephalus shunt is a medical device that helps treat a condition in the brain in which excessive accumulation of cerebrospinal fluid occurs, resulting in increased intracranial pressure within the skull. These devices relieve pressure on the brain caused by fluid accumulation. 

The hydrocephalus shunts market is segmented by product type, age group, end user, and geography. By product type, the market is segmented into hydrocephalus valves and hydrocephalus catheters (shunt systems). By age group, the market is segmented into pediatric and adult. By end user, the market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. By geography, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World. For each segment, the market size is provided in terms of value (USD).